Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Glutaminase: a hot spot for regulation of cancer cell metabolism?Erickson JW; Cerione RAOncotarget 2010[Dec]; 1 (8): 734-40Cancer cells re-program their metabolic machinery in order to satisfy their bioenergetic and biosynthetic requirements. A critical aspect of the re-programming of cancer cell metabolism involves changes in the glycolytic pathway (referred to as the "Warburg effect"). As an outcome of these changes, much of the pyruvate generated via the glycolytic pathway is converted to lactic acid, rather than being used to produce acetyl-CoA and ultimately, the citrate which enters the citric acid cycle. In order to compensate for these changes and to help maintain a functioning citric acid cycle, cancer cells often rely on elevated glutamine metabolism. Recently, we have found that this is achieved through a marked elevation of glutaminase activity in cancer cells. Here we further consider these findings and the possible mechanisms by which this important metabolic activity is regulated.|Animals[MESH]|Cell Transformation, Neoplastic/drug effects/genetics/metabolism[MESH]|Energy Metabolism/drug effects/*genetics[MESH]|Enzyme Inhibitors/pharmacology[MESH]|Glutaminase/antagonists & inhibitors/genetics/metabolism/*physiology[MESH]|Humans[MESH]|Metabolic Networks and Pathways/drug effects/genetics[MESH]|Models, Biological[MESH]|Neoplasms/*genetics/*metabolism[MESH]|rho GTP-Binding Proteins/genetics/metabolism/physiology[MESH] |